Skip to content

Transplanting Lungs From Uncontrolled Donation After Circulatory Death

Transplanting Lungs From Uncontrolled Donation After Circulatory Death: An Early Phase Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06327945
Enrollment
24
Registered
2024-03-25
Start date
2025-01-24
Completion date
2028-06-30
Last updated
2025-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplantation

Brief summary

The study team developed an uncontrolled donation after circulatory death (uDCD) protocol that preserves lungs for just over 3 hours after death using positive end expiratory pressure (PEEP) and supplemental oxygen. The study will assess lung uDCD program safety by continuous review of operations/clinical records from each case activation and transplantation. Attrition outcomes include rates of initial and continued lung preservation, donation authorization, lung recovery, passing ex-vivo lung perfusion (EVLP) performance testing, and lung transplantation. Planned viability assessments also include macroscopic determination, radiology (X-ray), and fiber optic bronchoscopy before initiating EVLP. We expect \ 50% of lungs assessed with EVLP will be transplanted to meet sustainability targets. Safety outcomes include the primary outcome, primary graft dysfunction (PGD) grade III at 72 hours, and secondarily survival one year after transplantation.

Interventions

DEVICELung uDCD Protocol

The intervention is initiation of PEEP and supplemental oxygen, without requiring prior permission (e.g., for cases not having first person authorization for organ donation and organ donation for research), to offer lung donation opportunities for cases which would otherwise be ineligible in the U.S.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients waiting for lung transplants * Willing to participate in the research study

Exclusion criteria

* Unable to be followed for 1 year after transplantation * Unable to provide written informed consent to participate in the research (or designate a surrogate)

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Primary Graft Dysfunction (PDG) Grade III72 Hours Post-TransplantPGD is measured 72 hours after transplantation and defined according to the International Society for Heart and Lung Transplantation (ISHLT) criteria: partial pressure of arterial oxygen divided by the fraction of inspired oxygen (Pa02/FI02) \< 200 mm Hg.

Secondary

MeasureTime frameDescription
Number of Participants who Required Normothermic Extracorporeal Membrane Oxygenation (nECMO)72 Hours Post-Transplant
Incidence of Re-Transplantation1 Year Post-Transplant
Overall Survival72 Hours Post-TransplantTime from transplant to death due to any cause.

Countries

United States

Contacts

Primary ContactCarolyn Sidoti
Carolyn.Sidoti@nyulangone.org646-987-1371

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026